Medicus Pharma (MDCX) Return on Capital Employed (2025 - 2026)

Medicus Pharma's (MDCX) quarterly Return on Capital Employed came in at 23242.91% in Q4 2025, down 370.68% on a QoQ basis from 4938.19% in Q3 2025.

Medicus Pharma (MDCX) Return on Capital Employed (2025 - 2026) Analysis & Trends

Medicus Pharma (MDCX) has 1 years of Return on Capital Employed data on file, last reported at 23242.91% in Q4 2025.

Quarterly Return on Capital Employed changed N/A year-over-year to 23242.91% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 23242.91% (changed N/A YoY) and the FY2025 annual result came in at 1648.77%, up 241263.0% from the prior year.
Return on Capital Employed declined to 23242.91% in Q4 2025, from 4938.19% in the prior quarter.
In the past five years, Return on Capital Employed ranged from a high of 630.27% in Q1 2025 to a low of 23242.91% in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROCE (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	17.83%
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	17.92%
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	9.96%
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	-
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	16.76%
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	16.66%
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	-5.97%
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	11.86%
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	11.42%
10	Medicus Pharma	14.88 Mn	-298,205.43	-	-326.38%

Download Data